» Articles » PMID: 17079667

Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: a Role for Tumor Necrosis Factor-induced Peptidylarginine Deiminase 4 Translocation

Overview
Journal J Neurosci
Specialty Neurology
Date 2006 Nov 3
PMID 17079667
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Modification of arginine residues by citrullination is catalyzed by peptidylarginine deiminases (PADs), of which five are known, generating irreversible protein structural modifications. We have shown previously that enhanced citrullination of myelin basic protein contributed to destabilization of the myelin membrane in the CNS of multiple sclerosis (MS) patients. We now report increased citrullination of nucleosomal histones by PAD4 in normal-appearing white matter (NAWM) of MS patients and in animal models of demyelination. Histone citrullination was attributable to increased levels and activity of nuclear PAD4. PAD4 translocation into the nucleus was attributable to elevated tumor necrosis factor-alpha (TNF-alpha) protein. The elevated TNF-alpha in MS NAWM was not associated with CD3+ or CD8+ lymphocytes, nor was it associated with CD68+ microglia/macrophages. GFAP, a measure of astrocytosis, was the only cytological marker that was consistently elevated in the MS NAWM, suggesting that TNF-alpha may have been derived from astrocytes. In cell cultures of mouse and human oligodendroglial cell lines, PAD4 was predominantly cytosolic but TNF-alpha treatment induced its nuclear translocation. To address the involvement of TNF-alpha in targeting PAD4 to the nucleus, we found that transgenic mice overexpressing TNF-alpha also had increased levels of citrullinated histones and elevated nuclear PAD4 before demyelination. In conclusion, high citrullination of histones consequent to PAD4 nuclear translocation is part of the process that leads to irreversible changes in oligodendrocytes and may contribute to apoptosis of oligodendrocytes in MS.

Citing Articles

Neutrophils, NETs and multiple sclerosis: a mini review.

Quan M, Zhang H, Deng X, Liu H, Xu Y, Song X Front Immunol. 2025; 16:1487814.

PMID: 39935468 PMC: 11810747. DOI: 10.3389/fimmu.2025.1487814.


Protein Citrullination in Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases.

Yusuf I, Camille W, Thompson P, Xu Z J Exp Neurol. 2024; 5(4):183-191.

PMID: 39712644 PMC: 11661818. DOI: 10.33696/neurol.5.101.


Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson's Disease Rat Model.

Mercer A, Sancandi M, Maclatchy A, Lange S Int J Mol Sci. 2024; 25(20).

PMID: 39456949 PMC: 11509057. DOI: 10.3390/ijms252011168.


A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis.

Manna I, De Benedittis S, Porro D Int J Mol Sci. 2024; 25(16).

PMID: 39201606 PMC: 11355011. DOI: 10.3390/ijms25168921.


Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson's Disease.

Hamidpour S, Amiri M, Haj Mohamad Ebrahim Ketabforoush A, Saeedi S, Angaji A, Tavakol S Mol Neurobiol. 2024; 61(11):8928-8966.

PMID: 38573414 DOI: 10.1007/s12035-024-04128-1.


References
1.
Kassiotis G, Bauer J, Akassoglou K, Lassmann H, Kollias G, Probert L . A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur J Immunol. 1999; 29(3):912-7. DOI: 10.1002/(SICI)1521-4141(199903)29:03<912::AID-IMMU912>3.0.CO;2-G. View

2.
Rusd A, Ikejiri Y, Ono H, Yonekawa T, Shiraiwa M, Kawada A . Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. Eur J Biochem. 1999; 259(3):660-9. DOI: 10.1046/j.1432-1327.1999.00083.x. View

3.
Ensoli F, Fiorelli V, Muratori D, De Cristofaro M, Vincenzi L, Topino S . Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators?. Crit Rev Immunol. 1999; 19(2):97-116. View

4.
Ye P, DErcole A . Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology. 1999; 140(7):3063-72. DOI: 10.1210/endo.140.7.6754. View

5.
Ladiwala U, Li H, Antel J, Nalbantoglu J . p53 induction by tumor necrosis factor-alpha and involvement of p53 in cell death of human oligodendrocytes. J Neurochem. 1999; 73(2):605-11. DOI: 10.1046/j.1471-4159.1999.0730605.x. View